Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1984 1
1986 1
1987 1
1988 1
1992 1
1994 1
2001 1
2005 2
2006 1
2008 1
2009 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation"
Page 1
Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?
Berger F, Traverse-Glehen A, Felman P, Callet-Bauchu E, Baseggio L, Gazzo S, Thieblemont C, Ffrench M, Magaud JP, Salles G, Coiffer B. Berger F, et al. Clin Lymphoma. 2005 Mar;5(4):220-4. doi: 10.3816/clm.2005.n.003. Clin Lymphoma. 2005. PMID: 15794852 Review.
Waldenstrom's macroglobulinemia (WM) is considered in the World Health Organization classification as a clinical syndrome associated with monoclonal immunoglobulin (Ig) M secretion, mainly observed in patients with lymphoplasmacytic lymphoma (LPL) and occasionally with oth …
Waldenstrom's macroglobulinemia (WM) is considered in the World Health Organization classification as a clinical syndrome associated with mo …
"Well-differentiated" lymphocytic neoplasms. Immunologic findings correlated with clinical presentation and morphologic features.
Medeiros LJ, Strickler JG, Picker LJ, Gelb AB, Weiss LM, Warnke RA. Medeiros LJ, et al. Am J Pathol. 1987 Dec;129(3):523-35. Am J Pathol. 1987. PMID: 3322023 Free PMC article.
The authors studied 48 cases of well-differentiated lymphocytic neoplasms using a panel of monoclonal antibodies applied to frozen sections. ...In contrast to the markedly different clinical presentation and morphologic appearance these tumors may have, the immunolo …
The authors studied 48 cases of well-differentiated lymphocytic neoplasms using a panel of monoclonal antibodies applied to fr …
Chronic B-lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitro.
Ostlund L, Einhorn S, Robèrt KH, Juliusson G, Biberfeld P. Ostlund L, et al. Blood. 1986 Jan;67(1):152-9. Blood. 1986. PMID: 2416366 Free article.
The ability of interferon (IFN) to induce proliferation and differentiation in malignant B cells from 29 patients with chronic lymphocytic leukemia (CLL) and in lymphoid cells from 11 healthy donors was investigated. ...Maximal transformation and proli …
The ability of interferon (IFN) to induce proliferation and differentiation in malignant B cells from 29 patients with chronic …
Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.
Jilani I, Wei C, Bekele BN, Zhang ZJ, Keating M, Wierda W, Ferrajoli A, Estrov Z, Kantarjian H, O'Brien SM, Giles FJ, Albitar M. Jilani I, et al. Int J Lab Hematol. 2009 Feb;31(1):97-105. doi: 10.1111/j.1751-553X.2007.01010.x. Epub 2008 Jan 7. Int J Lab Hematol. 2009. PMID: 18190591 Free PMC article.
Syndecan-1 (sCD138) is a transmembrane heparan sulfate-bearing proteoglycan expressed in epithelial cells as well as hematopoietic cells that demonstrate plasmacytoid differentiation. Higher levels of sCD138 correlate with poor outcome in myeloma. We examined the as …
Syndecan-1 (sCD138) is a transmembrane heparan sulfate-bearing proteoglycan expressed in epithelial cells as well as hematopoietic cells tha …
Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
Moore EM, Swerdlow SH, Gibson SE. Moore EM, et al. Am J Surg Pathol. 2018 Mar;42(3):342-350. doi: 10.1097/PAS.0000000000001015. Am J Surg Pathol. 2018. PMID: 29309299
Its role in the differential diagnosis of B-cell lymphomas, particularly in the distinction of follicular lymphoma (FL) versus marginal zone lymphoma (MZL), remains to be determined. ...MEF2B was positive in all FL and Burkitt lymphomas, 8/9 mantle cell …
Its role in the differential diagnosis of B-cell lymphomas, particularly in the distinction of follicular lymphoma (FL) …
Functional heterogeneity and pathogenic significance of interleukin-6 in B-cell lymphomas.
Hsu SM, Xie SS, Waldron JA Jr. Hsu SM, et al. Am J Pathol. 1992 Oct;141(4):915-23. Am J Pathol. 1992. PMID: 1415484 Free PMC article.
A possible autocrine effect of interleukin-6 (IL-6) on the growth and differentiation of the tumor cells of 55 B-cell lymphomas was examined. Interleukin-6 was detected in a few types of B-cell lymphomas, including polymorphic immunocytoma (PI), …
A possible autocrine effect of interleukin-6 (IL-6) on the growth and differentiation of the tumor cells of 55 B-cell l …
Differentiation of chronic lymphocytic leukemia cells after in vitro treatment with Epstein-Barr virus or phorbol ester. I. Immunologic and morphologic studies.
Deegan MJ, Maeda K. Deegan MJ, et al. Am J Hematol. 1984;17(4):335-47. doi: 10.1002/ajh.2830170403. Am J Hematol. 1984. PMID: 6093504
Leukemic cells from ten patients with "nonsecretory," B-type chronic lymphocytic leukemia (CLL) were cultured alone or in the presence of Epstein-Barr virus (EBV) or a phorbol ester (12-0-tetradecanoylphorbol-13-acetate; TPA) for 7 days. ...These studies indi …
Leukemic cells from ten patients with "nonsecretory," B-type chronic lymphocytic leukemia (CLL) were cultured alone or …
Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells.
Tötterman TH, Nilsson K, Sundström C. Tötterman TH, et al. Nature. 1980 Nov 13;288(5787):176-8. doi: 10.1038/288176a0. Nature. 1980. PMID: 7432517
TPA induces a terminal cell differentiation in some murine and human myeloid leukaemia and histiocytic lymphoma cells. We report here the effect of TPA on chronic lymphocytic leukaemia (CLL) biopsy cells in vitro. In four out of five CLL patient …
TPA induces a terminal cell differentiation in some murine and human myeloid leukaemia and histiocytic lymphoma cells. We repo …
Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases.
Andriko JA, Swerdlow SH, Aguilera NI, Abbondanzo SL. Andriko JA, et al. Am J Surg Pathol. 2001 Jun;25(6):742-51. doi: 10.1097/00000478-200106000-00005. Am J Surg Pathol. 2001. PMID: 11395551
Lymphoplasmacytic lymphoma/immunocytoma (LLI) was defined initially as a small B-cell lymphoma with plasmacytoid or plasmacytic features. Because other types of small B-cell lymphoma, particularly marginal zone B-cell lymphoma may …
Lymphoplasmacytic lymphoma/immunocytoma (LLI) was defined initially as a small B-cell lymphoma with plasmacytoid or pla …
Immunologic characterization and ultrastructural correlations for 125 cases of B- and T-cell leukemias: studies of chronic and acute lymphocytic, prolymphocytic, lymphosarcoma cell and hairy cell leukemia, Sezary's syndrome, and other lymphoid leukemias.
Said JW, Pinkus GS. Said JW, et al. Cancer. 1981 Dec 15;48(12):2630-42. doi: 10.1002/1097-0142(19811215)48:12<2630::aid-cncr2820481215>3.0.co;2-p. Cancer. 1981. PMID: 6975649
B-cell leukemias (comprised 82% of the series and included chronic lymphocytic leukemia (69/71 cases), acute lymphocytic leukemia (1/18 cases), lymphosarcoma cell leukemia (15/18 cases), prolymphocytic leukemia …
B-cell leukemias (comprised 82% of the series and included chronic lymphocytic leukemia (69/71 cases), ac …
13 results